Biological Characterization of F508delCFTR Protein Processing by the CFTR Corrector ABBV-2222/GLPG2222
Ashvani K. Singh(AbbVie (United States)), Chris Tse(AbbVie (United States)), Timothy A. Vortherms(University of North Carolina at Chapel Hill), Corina Balut(University of North Carolina at Chapel Hill), Katja Conrath(Galapagos (Belgium)), Andrew M. Swensen(Harvard University), Douglas Cyr(University of North Carolina at Chapel Hill), Philip R. Kym(AbbVie (United States)), Arlene M. Manelli(University of North Carolina at Chapel Hill), Torben R. Neelands(University of North Carolina at Chapel Hill), Ying Jia(Shenyang Pharmaceutical University), Bo Liu(University of North Carolina at Chapel Hill), Xueqing Wang(University of North Carolina at Chapel Hill), Tzyh‐Chang Hwang(National Yang Ming Chiao Tung University), Wenqing Gao(Tianjin University), Yihong Fan, Hong Yu Ren(University of North Carolina at Chapel Hill), Sara Alani(University of North Carolina at Chapel Hill), Xenia B. Searle(University of North Carolina at Chapel Hill)
Cited by 29
Related Papers
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
|Nature Medicine|2013|3k
Exploiting selective BCL-2 family inhibitors to dissect cell survival dependencies and define improved strategies for cancer therapy
|Science Translational Medicine|2015|541
Discovery of a Potent and Selective BCL-X <sub>L</sub> Inhibitor with <i>in Vivo</i> Activity
|ACS Medicinal Chemistry Letters|2014|331
Ionic Mechanisms of Burst Firing in Dissociated Purkinje Neurons
|Journal of Neuroscience|2003|219
Robustness of Burst Firing in Dissociated Purkinje Neurons with Acute or Long-Term Reductions in Sodium Conductance
|Journal of Neuroscience|2005|210